Consequently, investigating the mechanisms by which MDSCs directly regulate breast cancer cells to promote tumor progression is crucial for developing an effective therapeutic strategy for PIK3CA-mutated HR + breast cancer patients. The gene discussed is PIK3CA; the disease is breast carcinoma.